Genome Biology Group
The research group aims to improve the diagnosis and management of cancer by utilizing genome technologies. The research projects are primarily performed on biobank material from prostate cancer, although projects on testicular, colorectal, and ovarian cancers are as well being pursued. Cancer genomes and transcriptomes are studied by a combination of computational biology and wet-lab based approaches. Mutation analyses in cancer clearly benefit from knowing which genes and variants that are actually expressed. In this line, the group has particularly specialized in RNA-level analyses. To perform meaningful genome-scale cancer research, interdisciplinary expertise is required. As such, the personnel have their basic education across the disciplines of biology, informatics, and medicine.
The research group includes a project group in Cancer informatics, led by Dr. Bjarne Johannessen.
Interfocal heterogeneity of prostate cancer, and implications for precision cancer management
RNA variation caused by aberrant splicing and as a source of cancer biomarkers
Fusion gene identification and characterisation
Department of Molecular Oncology, Institute for Cancer Research
Oslo University Hospital-Radiumhospitalet
P.O.Box 4953 Nydalen, NO-0424 Oslo, Norway
Phone: +47 2278 1727 / +47 2293 4000
E mail: email@example.com